Expert Details
Vaccine Development
ID: 734292
Belgium
Overall, development of more than 50 projects (bacterial, viral, recombinant yeast, CHO, viruses, E.coli and adjuvant systems)with signifiant contribution for 12 products launched in EU/US
7 US patents granted
Experience in QC, Engineering, Facility design, EHS,
Management of approximately 20 Joint Ventures and Partnerships.
Have left GSK Biologicals in 2018, now working as an independent consultant with last 2 functions VP, Head of R&D Asia and VP, Head of Asia strategic partnerships(Based in China for 8 years)
Starting activities
Current projects:
- review CTD vaccine file for client before submission for WHO prequalification
- support assessment of vaccine facilities for client acquisition
- identify source for vaccine seeds for technology transfers
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1981 | Degree: Civil Engineer | Subject: Bioengineer | Institution: University Gembloux, BE |
| Year: 1986 | Degree: PhD | Subject: Agronomical Sciences | Institution: University Gembloux, BE |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 1987 to Present | Employer: Undisclosed | Title: VP | Department: R&D |
Responsibilities:Successively Process development Head, Dir Pilot Plant Head, Dir R&D partnerships Head, VP Asia R&D Head, VP Asia Strategic Parnerships Head |
|||
International Experience
| Years | Country / Region | Summary |
|---|---|---|
| Years: 1989 to 2008 | Country / Region: Asia based in China | Summary: R&D head and Strategic Partnership management head |
Language Skills
| Language | Proficiency |
|---|---|
| French | Mother language |
| English | Fluent |